• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T138067(一种对多药耐药肿瘤具有体内疗效的抗肿瘤药物)对β-微管蛋白残基Cys-239进行选择性、共价修饰。

Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors.

作者信息

Shan B, Medina J C, Santha E, Frankmoelle W P, Chou T C, Learned R M, Narbut M R, Stott D, Wu P, Jaen J C, Rosen T, Timmermans P B, Beckmann H

机构信息

Tularik Inc., Two Corporate Drive, South San Francisco, CA 94080, USA.

出版信息

Proc Natl Acad Sci U S A. 1999 May 11;96(10):5686-91. doi: 10.1073/pnas.96.10.5686.

DOI:10.1073/pnas.96.10.5686
PMID:10318945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC21921/
Abstract

Microtubules are linear polymers of alpha- and beta-tubulin heterodimers and are the major constituents of mitotic spindles, which are essential for the separation of chromosomes during mitosis. Here we describe a synthetic compound, 2-fluoro-1-methoxy-4-pentafluorophenylsulfonamidobenzene (T138067), which covalently and selectively modifies the beta1, beta2, and beta4 isotypes of beta-tubulin at a conserved cysteine residue, thereby disrupting microtubule polymerization. Cells exposed to T138067 become altered in shape, indicating a collapse of the cytoskeleton, and show an increase in chromosomal ploidy. Subsequently, these cells undergo apoptosis. Furthermore, T138067 exhibits cytotoxicity against tumor cell lines that exhibit substantial resistance to vinblastine, paclitaxel, doxorubicin, and actinomycin D. T138067 is also equally efficacious in inhibiting the growth of sensitive and multidrug-resistant human tumor xenografts in athymic nude mice. These observations suggest that T138067 may be clinically useful for the treatment of multidrug-resistant tumors.

摘要

微管是α-和β-微管蛋白异二聚体的线性聚合物,是有丝分裂纺锤体的主要成分,而有丝分裂纺锤体对于有丝分裂期间染色体的分离至关重要。在此,我们描述了一种合成化合物,2-氟-1-甲氧基-4-五氟苯磺酰胺苯(T138067),它在一个保守的半胱氨酸残基处共价且选择性地修饰β-微管蛋白的β1、β2和β4亚型,从而破坏微管聚合。暴露于T138067的细胞形状发生改变,表明细胞骨架塌陷,并显示染色体倍性增加。随后,这些细胞发生凋亡。此外,T138067对显示出对长春碱、紫杉醇、阿霉素和放线菌素D具有显著抗性的肿瘤细胞系表现出细胞毒性。T138067在抑制无胸腺裸鼠中敏感和多药耐药的人肿瘤异种移植物生长方面同样有效。这些观察结果表明,T138067在临床上可能对多药耐药肿瘤的治疗有用。

相似文献

1
Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors.T138067(一种对多药耐药肿瘤具有体内疗效的抗肿瘤药物)对β-微管蛋白残基Cys-239进行选择性、共价修饰。
Proc Natl Acad Sci U S A. 1999 May 11;96(10):5686-91. doi: 10.1073/pnas.96.10.5686.
2
Hydrophilic, pro-drug analogues of T138067 are efficacious in controlling tumor growth in vivo and show a decreased ability to cross the blood brain barrier.T138067的亲水性前药类似物在体内控制肿瘤生长方面有效,且穿过血脑屏障的能力降低。
J Med Chem. 2001 Oct 25;44(22):3599-605. doi: 10.1021/jm000478d.
3
A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.A-204197,一种新型微管蛋白结合剂,对已知微管抑制剂耐药的肿瘤细胞系具有抗有丝分裂活性。
Cancer Res. 2001 Jul 15;61(14):5480-5.
4
Covalent modification of Cys-239 in β-tubulin by small molecules as a strategy to promote tubulin heterodimer degradation.小分子对β-微管蛋白 Cys-239 的共价修饰作为促进微管蛋白二聚体降解的策略。
J Biol Chem. 2019 May 17;294(20):8161-8170. doi: 10.1074/jbc.RA118.006325. Epub 2019 Apr 2.
5
Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo.土槿皮酸B,一种新型的微管去稳定剂,可规避多药耐药表型并在体内表现出抗肿瘤活性。
Clin Cancer Res. 2005 Aug 15;11(16):6002-11. doi: 10.1158/1078-0432.CCR-05-0209.
6
Glutathione S-transferase metabolism of the antineoplastic pentafluorophenylsulfonamide in tissue culture and mice.抗肿瘤五氟苯磺酰胺在组织培养和小鼠中的谷胱甘肽S-转移酶代谢
Drug Metab Dispos. 2000 Aug;28(8):951-8.
7
Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-Anticancer Drug Screen: correlation with sensitivity to microtubule active agents.β-微管蛋白同型异构体在人卵巢癌异种移植瘤及美国国立癌症研究所抗癌药物筛选的一组人类癌细胞系中的表达:与对微管活性剂敏感性的相关性
Clin Cancer Res. 2001 Sep;7(9):2912-22.
8
Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin.口服活性磺酰胺类抗肿瘤药物E7010的作用机制:通过与微管蛋白的秋水仙碱结合位点结合来抑制有丝分裂。
Cancer Res. 1997 Aug 1;57(15):3208-13.
9
Natural product derivative Bis(4-fluorobenzyl)trisulfide inhibits tumor growth by modification of beta-tubulin at Cys 12 and suppression of microtubule dynamics.天然产物衍生物双(4-氟苄基)三硫醚通过修饰 Cys12 上的β-微管蛋白和抑制微管动力学来抑制肿瘤生长。
Mol Cancer Ther. 2009 Dec;8(12):3318-30. doi: 10.1158/1535-7163.MCT-09-0548.
10
Indirubin, a bis-indole alkaloid binds to tubulin and exhibits antimitotic activity against HeLa cells in synergism with vinblastine.靛玉红,一种双吲哚生物碱,与微管蛋白结合,并与长春碱协同作用对 HeLa 细胞表现出抗有丝分裂活性。
Biomed Pharmacother. 2018 Sep;105:506-517. doi: 10.1016/j.biopha.2018.05.127. Epub 2018 Jun 6.

引用本文的文献

1
Identification of a Series Containing a Pentafluorophenyl Moiety That Targets Pks13 to Inhibit Growth of .鉴定出一个含有五氟苯基部分的系列,该系列靶向Pks13以抑制……的生长。
ACS Infect Dis. 2025 Mar 14;11(3):715-726. doi: 10.1021/acsinfecdis.4c00808. Epub 2025 Feb 27.
2
Diverse role, structural trends, and applications of fluorinated sulphonamide compounds in agrochemical and pharmaceutical fields.含氟磺酰胺化合物在农用化学品和制药领域的多样作用、结构趋势及应用
Heliyon. 2024 Jun 8;10(12):e32434. doi: 10.1016/j.heliyon.2024.e32434. eCollection 2024 Jun 30.
3
Allocolchicinoids bearing a Michael acceptor fragment for possible irreversible binding of tubulin.所有带有迈克尔受体片段的别秋水仙碱类化合物,用于与微管蛋白进行可能的不可逆结合。
RSC Med Chem. 2020 Jun 4;11(6):696-706. doi: 10.1039/d0md00060d. eCollection 2020 Jun 1.
4
A Multipronged Approach Establishes Covalent Modification of β-Tubulin as the Mode of Action of Benzamide Anti-cancer Toxins.多管齐下的方法确定了苯甲酰胺类抗癌毒素的作用模式为β-微管蛋白的共价修饰。
J Med Chem. 2020 Nov 25;63(22):14054-14066. doi: 10.1021/acs.jmedchem.0c01482. Epub 2020 Nov 12.
5
Covalent modification of Cys-239 in β-tubulin by small molecules as a strategy to promote tubulin heterodimer degradation.小分子对β-微管蛋白 Cys-239 的共价修饰作为促进微管蛋白二聚体降解的策略。
J Biol Chem. 2019 May 17;294(20):8161-8170. doi: 10.1074/jbc.RA118.006325. Epub 2019 Apr 2.
6
The compound millepachine and its derivatives inhibit tubulin polymerization by irreversibly binding to the colchicine-binding site in β-tubulin.该化合物米利定及其衍生物通过不可逆结合到β-微管蛋白的秋水仙素结合位点来抑制微管蛋白聚合。
J Biol Chem. 2018 Jun 15;293(24):9461-9472. doi: 10.1074/jbc.RA117.001658. Epub 2018 Apr 24.
7
Novel Natural Product- and Privileged Scaffold-Based Tubulin Inhibitors Targeting the Colchicine Binding Site.靶向秋水仙碱结合位点的基于新型天然产物和优势骨架的微管蛋白抑制剂
Molecules. 2016 Oct 15;21(10):1375. doi: 10.3390/molecules21101375.
8
Signal transducer and activator of transcription 3 (STAT3) inhibitor, S3I-201, acts as a potent and non-selective alkylating agent.信号转导与转录激活因子3(STAT3)抑制剂S3I-201是一种强效且非选择性的烷基化剂。
Oncotarget. 2016 Apr 12;7(15):20669-79. doi: 10.18632/oncotarget.7838.
9
Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?稳定微管与破坏微管:癌症有效治疗选择的双刃剑?
Anal Cell Pathol (Amst). 2015;2015:690916. doi: 10.1155/2015/690916. Epub 2015 Sep 21.
10
Design, synthesis, and biological evaluation of stable colchicine binding site tubulin inhibitors as potential anticancer agents.稳定型秋水仙碱结合位点微管蛋白抑制剂作为潜在抗癌药物的设计、合成及生物学评价
J Med Chem. 2014 Sep 11;57(17):7355-66. doi: 10.1021/jm500764v. Epub 2014 Aug 26.

本文引用的文献

1
Microtubules and actin filaments: dynamic targets for cancer chemotherapy.微管和肌动蛋白丝:癌症化疗的动态靶点。
Curr Opin Cell Biol. 1998 Feb;10(1):123-30. doi: 10.1016/s0955-0674(98)80095-1.
2
Function, evolution and structure of multidrug resistance protein (MRP).多药耐药蛋白(MRP)的功能、进化与结构
Semin Cancer Biol. 1997 Jun;8(3):193-204. doi: 10.1006/scbi.1997.0070.
3
Structure of the alpha beta tubulin dimer by electron crystallography.通过电子晶体学解析αβ微管蛋白二聚体的结构。
Nature. 1998 Jan 8;391(6663):199-203. doi: 10.1038/34465.
4
Coupling cell division and cell death to microtubule dynamics.将细胞分裂和细胞死亡与微管动力学相耦合。
Curr Opin Cell Biol. 1997 Dec;9(6):807-14. doi: 10.1016/s0955-0674(97)80081-6.
5
Microtubule dynamics: taking aim at a moving target.微管动力学:瞄准移动目标
Chem Biol. 1995 Sep;2(9):569-73. doi: 10.1016/1074-5521(95)90119-1.
6
The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents.紫杉烷类抗微管化疗药物的研发及临床应用
Annu Rev Med. 1997;48:353-74. doi: 10.1146/annurev.med.48.1.353.
7
The dual role of mutant p53 protein in chemosensitivity of human cancers.突变型p53蛋白在人类癌症化疗敏感性中的双重作用。
Anticancer Res. 1996 Nov-Dec;16(6B):3845-8.
8
When checkpoints fail.当检查点失败时。
Cell. 1997 Feb 7;88(3):315-21. doi: 10.1016/s0092-8674(00)81870-x.
9
P-glycoprotein and multidrug resistance.P-糖蛋白与多药耐药性。
Curr Opin Genet Dev. 1996 Oct;6(5):610-7. doi: 10.1016/s0959-437x(96)80091-8.
10
Localization of the vinblastine-binding site on beta-tubulin.长春碱在β-微管蛋白上结合位点的定位
J Biol Chem. 1996 Jun 21;271(25):14707-11. doi: 10.1074/jbc.271.25.14707.